ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Growth Shares
Top ASX shares to buy now for long-term growth
Healthcare Shares
1 Australian stock you'll probably kick yourself for not owning a decade from now
Broker Notes
5 ASX 200 large-cap shares re-rated by Morgans
How to invest
The Warren Buffett golden rule that investors can't ignore
Blue Chip Shares
These top ASX 200 stocks could rise 25% to 60%
Broker Notes
Macquarie reveals ASX 200 share tips in each market sector for 2026
How to invest
Want to build wealth? Here's how Warren Buffett does it
Retirement
No savings at 55? Here's how to still retire with passive income
How to invest
What I'd buy first if the ASX share market fell 30%
Broker Notes
These ASX 200 shares could rise 25% to 30%
How to invest
How to make $50,000 of passive income a year from ASX shares
How to invest
My plan of attack for the next share market crash
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
